Pharmaceutical composition, methods for treating and uses thereof

  • US 9,949,998 B2
  • Filed: 10/21/2015
  • Issued: 04/24/2018
  • Est. Priority Date: 04/05/2013
  • Status: Active Grant
First Claim
Patent Images

1. A method for improving glycemic control in a patient with type 2 diabetes mellitus comprising administering empagliflozin to the patient if the eGFR of the patient is ≥

  • 45 ml/min/1.73 m2 and <

    60 ml/min/1.73 m2, wherein empagliflozin is administered orally once daily as a pharmaceutical composition comprising 10 mg or 25 mg of empagliflozin, wherein the glycemic control in said patient is improved, and discontinuing empagliflozin if the eGFR of the patient falls below 45 ml/min/1.73 m2.

View all claims

    Thank you for your feedback